Phase II randomized study of oral uracil/tegafur (UFT) plus leucovorin (LV) or parenteral 5-Fluorouracil (5-FU) plus leucovorin in patients with metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Sizer, B. [2 ]
Makris, A. [1 ]
Barone, C. [3 ]
Bordonaro, R. [4 ]
Hausmaninger, H. [5 ]
Steger, G. [6 ]
Aloe, A. [7 ]
Peeters, O. [7 ]
Donato, B. [7 ]
机构：
[1] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[2] Essex Cty Hosp, Colchester, Essex, England
[3] Univ Cattolica, Rome, Italy
[4] Osped S Luigi, Catania, Italy
[5] Salzburg Hosp, Salzburg, Austria
[6] Med Univ, Vienna, Austria
[7] Bristol Myers Squibb Pharmaceut Res Inst, Braine Lalleud, Belgium
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [21] Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer
    Wang, WS
    Lin, JK
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Lin, TC
    Jiang, JK
    Yang, SH
    Chen, PM
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1599 - 1603
  • [22] Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
    Makoto Meguro
    Tomohisa Furuhata
    Kenji Okita
    Toshihiko Nishidate
    Gentaro Ishiyama
    Yuji Iwayama
    Yasutoshi Kimura
    Toru Mizuguchi
    Koichi Hirata
    International Journal of Clinical Oncology, 2009, 14 : 402 - 407
  • [23] Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
    Meguro, Makoto
    Furuhata, Tomohisa
    Okita, Kenji
    Nishidate, Toshihiko
    Ishiyama, Gentaro
    Iwayama, Yuji
    Kimura, Yasutoshi
    Mizuguchi, Toru
    Hirata, Koichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 402 - 407
  • [24] Trimetrexate (TMTX) modulation of 5-fluorouracil leucovorin (5-FU/LV) for advanced colorectal cancer
    Blanke, C
    Kasimis, B
    Schein, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 748 - 748
  • [25] 5-FLUOROURACIL, LEUCOVORIN AND IRINOTECAN (FOLFIRI) PLUS BEVACIZUMAB (BV) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A MULTICENTER PHASE II TRIAL
    Cordio, S.
    Parra, Soto H. J.
    Pumo, V
    Condorelli, S.
    Latteri, F.
    Sambataro, D.
    Rosati, G.
    Aprile, G.
    Fassari, G.
    De Pauli, F.
    Rimassa, L.
    Bordonaro, R.
    ANNALS OF ONCOLOGY, 2009, 20
  • [26] A phase II study with 5-fluorouracil (5FU), leucovorin (LV) and irinotecan (CPT-11) in patients with metastatic colorectal cancer
    Destefanis, M
    Dalla Mola, A
    Ostellino, O
    Capello, C
    Milanesi, E
    Grillo, C
    Castiglione, F
    Venturino, A
    Porcile, G
    ANNALS OF ONCOLOGY, 2000, 11 : 67 - 67
  • [27] A phase I/II study of tegafur-uracil (UFT) plus oral leucovorin (LV) and biweekly CPT-11 therapy for patients (pts) with metastatic colorectal cancer (CRC).
    Uetake, H
    Tetsuro, H
    Enomoto, M
    Sugihara, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 303S - 303S
  • [28] A simplified bi-monthly regimen with leucovorin (LV) and 5-Fluorouracil (5FU) for metastatic colorectal cancer (MCRC)
    Tournigand, C
    de Gramont, A
    Louvet, C
    Andre, T
    Carola, E
    Gilles-Amar, V
    Maindrault-Goebel, F
    Lotz, JP
    Molitor, JL
    ANNALS OF ONCOLOGY, 1998, 9 : 40 - 40
  • [29] Phase I and Pharmacokinetic Study of Tegafur-Uracil/Leucovorin Combined With 5-Fluorouracil/Leucovorin and Irinotecan in Patients With Advanced Colorectal Cancer
    Chayahara, Naoko
    Tamura, Takao
    Yamamori, Motohiro
    Kadowaki, Yuko
    Okuno, Tatsuya
    Miki, Ikuya
    Tsuda, Masahiro
    Nishisaki, Hogara
    Maeda, Tetsuo
    Inoue, Yoshifumi
    Okumura, Katsuhiko
    Azuma, Takeshi
    Kasuga, Masato
    Sakaeda, Toshiyuki
    Hirai, Midori
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 56 - 60
  • [30] Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer
    Tsavaris, N
    Kosmas, C
    Gennatas, K
    Vadiaka, M
    Skopelitis, E
    Xila, V
    Rokana, S
    Margaris, E
    Zografos, G
    Papastratis, G
    Kouraklis, G
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (04) : 406 - 411
12345